Fungal Skin Infections

Fungus can cause many infections like athlete’s foot, ringworm, jock itch, and others. Many over the counter and prescription treatments are available, but as resistant strains are found a new treatment may need to be used. The combination of the usual antifungal and ibuprofen has been shown to be a successful alternative. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.
https://www.ncbi.nlm.nih.gov/pubmed?term=10966233

Head Lice

Common treatments of head lice use a pediculicide that works as a neurotoxic agent against the lice to kill them.  This treatment can both raise concerns for the patient being treated and can be ineffective against resistant populations. Compounded products that work in a different way can offer new alternatives. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment.

https://www.ncbi.nlm.nih.gov/pubmed?term=22382818

Effectiveness of lotions based on essential oils from aromatic plants against permethrin resistant Pediculus humanus capitis.
https://www.ncbi.nlm.nih.gov/pubmed?term=17647002

Molluscum Contagiosum

This skin condition is currently rarely treated as it is usually a self-limiting infection. Sometimes an infection can cause secondary skin infections, or the infection may not go away on its own if the patient’s immune system is weak. In these cases treatment may be necessary. Treatment of molluscum contagiosum with silver nitrate paste.
https://www.ncbi.nlm.nih.gov/pubmed?term=10571843

Pulmonary Arterial Hypertension

Most medications on the market for pulmonary hypertension are not made in appropriate strengths or forms for use in children. Medications can be compounded to make them child appropriate including new therapies emerging like sildenafil. The use of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Review of the Literature.
https://www.ncbi.nlm.nih.gov/pubmed?term=22564297 

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
https://www.ncbi.nlm.nih.gov/pubmed?term=15956137

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
https://www.ncbi.nlm.nih.gov/pubmed?term=19768639

Topical Anesthetics & Analgesics

Pain management often involves oral pain medications, but this can come with many side effects. The use of topical agents can help avoid systemic side effects while still being successful in managing pain. Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.
https://www.ncbi.nlm.nih.gov/pubmed?term=12761001 

Topical amitriptyline in healthy volunteers.
https://www.ncbi.nlm.nih.gov/pubmed?term=12945021 

Topical analgesics.
https://www.ncbi.nlm.nih.gov/pubmed?term=22440379

Local application of strong opioids and wound-related pain.
https://www.ncbi.nlm.nih.gov/pubmed?term=22216634 

Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
https://www.ncbi.nlm.nih.gov/pubmed?term=9915332